Active psoriasis and profound CD4+ lymphocytopenia

British Journal of Dermatology

Volumn 136, Issue 6, 1997, Pages 930-932

  Hardman, C M ^a   Baker, B S ^a   Lortan, J ^a   Breuer, J ^b   Surentheran, T ^b   Powles, A ^a   Fry, L ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; HELPER CELL; HUMAN; HUMAN TISSUE; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN CARCINOMA; T LYMPHOCYTE ACTIVATION; WART VIRUS;

EID: 0030844706     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03936.x     Document Type: Article

References (15)

1. + T lymphocytopenia - an analysis of five patients with unexplained opportunistic infections. N Engl J Med 1993; 328: 386-92.
2. + T lymphocytopenia without HIV infection. N Engl J Med 1993; 328: 373-9.
3. + lymphocyte counts. Br J Dermatol 1995; 133: 625-9.
4. + lymphocyte deficiency. Report of an unusual case associated with atopic dermatitis and allergic contact dermatitis and review of the literature. Arch Dermatol 1993; 129: 876-8.
5. + T lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome. Clin Exp Rheum 1995; 13: 609-16.
6. + T lymphocytopenia - immunodeficiency without evidence of HIV infection. N Engl J Med 1993; 328: 380-5.
7. Baker BS, Swain AF, Fry L et al. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110: 555-64.
8. Baker BS, Swain AF, Griffiths CEM et al. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol 1985; 61: 526-34.
9. Baker BS, Griffiths CEM, Lambert S et al. The effects of cyclosporin A on T lymphocyte and dendritic cell subpopulations in psoriasis. Br J Dermatol 1987; 116: 503-10.
10. Baker BS, Powles AV, Savage CR et al. Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations. Br J Dermatol 1989; 120: 207-13.
11. Cobb MW. Continuing medical education. Human papilloma virus infection. J Am Acad Dermatol 1990; 22: 547-66.
12. Harwood CM, Spink PJ, Surentheran T. Epidermodysplasia verruciformis-type human papilloma viruses in PUVA-associated non-melanoma skin cancers. Br J Dermatol 1997; 136: 445.
13. Steigleder GK, Rasokat H, Wemmer U. Psoriasis in immune deficiency related to HTLV III cellular immunity and immunohistochemical findings. Z Hautkr 1986; 61: 1671-8.
14. Valdimarsson V, Baker BS, Jonisdottir I et al. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256-9.
15. + T cells in psoriatic lesions preferentially use T-cell receptor V β 3 and/or V β 13.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282-6.